Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed
Publication
, Journal Article
Zafar, Y; Hurwitz, HI
Published in: ONCOLOGY-NEW YORK
July 1, 2007
Duke Scholars
Published In
ONCOLOGY-NEW YORK
ISSN
0890-9091
Publication Date
July 1, 2007
Volume
21
Issue
8
Start / End Page
976 / 977
Publisher
UBM MEDICA
Citation
APA
Chicago
ICMJE
MLA
NLM
Zafar, Y., & Hurwitz, H. I. (2007). Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed. ONCOLOGY-NEW YORK, 21(8), 976–977.
Zafar, Yousuf, and Herbert I. Hurwitz. “Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed.” ONCOLOGY-NEW YORK 21, no. 8 (July 1, 2007): 976–77.
Zafar Y, Hurwitz HI. Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed. ONCOLOGY-NEW YORK. 2007 Jul 1;21(8):976–7.
Zafar, Yousuf, and Herbert I. Hurwitz. “Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed.” ONCOLOGY-NEW YORK, vol. 21, no. 8, UBM MEDICA, July 2007, pp. 976–77.
Zafar Y, Hurwitz HI. Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed. ONCOLOGY-NEW YORK. UBM MEDICA; 2007 Jul 1;21(8):976–977.
Published In
ONCOLOGY-NEW YORK
ISSN
0890-9091
Publication Date
July 1, 2007
Volume
21
Issue
8
Start / End Page
976 / 977
Publisher
UBM MEDICA